PEOPLE - US Biotechnology Industry Association makes appointment:
This article was originally published in Clinica
The US Biotechnology Industry Association (Washington, DC) has appointed John Taylor as executive vice-president for its health division. Mr Taylor, who was most recently divisional vice-president for federal government affairs at diversified medtech firm Abbott, is an industry veteran. For 14 years, Mr Taylor served the US Food and Drug Administration, most recently as associate commissioner for regulatory affairs.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.